Eric Coldwell
Stock Analyst at Baird
(5.00)
# 10
Out of 4,876 analysts
193
Total ratings
56.48%
Success rate
129.07%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Neutral | $9 → $10 | $8.87 | +12.74% | 18 | Jun 6, 2025 | |
| PINC Premier | Maintains: Neutral | $19 → $22 | $21.61 | +1.80% | 8 | May 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $150.01 | -6.67% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $157.47 | +2.24% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $144.56 | +10.68% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $167.18 | +1.69% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $260.59 | +2.46% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $310.69 | +0.74% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $177.83 | +9.09% | 10 | Apr 23, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $9.55 | +67.54% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $4.98 | +402.01% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $725.78 | -5.21% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.45 | +345.41% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $61.73 | -27.10% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $68.49 | -3.64% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.49 | +2,987.25% | 4 | Nov 10, 2017 |
Owens & Minor
Jun 6, 2025
Maintains: Neutral
Price Target: $9 → $10
Current: $8.87
Upside: +12.74%
Premier
May 15, 2025
Maintains: Neutral
Price Target: $19 → $22
Current: $21.61
Upside: +1.80%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $150.01
Upside: -6.67%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $157.47
Upside: +2.24%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $144.56
Upside: +10.68%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $167.18
Upside: +1.69%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $260.59
Upside: +2.46%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $310.69
Upside: +0.74%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $177.83
Upside: +9.09%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.55
Upside: +67.54%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $4.98
Upside: +402.01%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $725.78
Upside: -5.21%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.45
Upside: +345.41%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $61.73
Upside: -27.10%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $68.49
Upside: -3.64%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.49
Upside: +2,987.25%